Literature DB >> 15309230

[Prevalence of pathologic gastroesophageal reflux in regurgitant infants].

Aldo J F Costa1, Giselia A P Silva, Pedro A C Gouveia, Ernani M Pereira Filho.   

Abstract

OBJECTIVE: To determine the prevalence of pathologic gastroesophageal reflux in a group of regurgitant infants attended at Helena Moura Hospital, Recife, State of Pernambuco, Brazil. The clinical criteria employed were based on Rome II criteria.
METHOD: The study design was transversal. The patients were all children of less than 1 year of age with a history of episodes of regurgitation for at least 3 weeks. The study group was comprised of 798 children who attended the program between January and August of 2002. The diagnostic criteria were based on Rome II criteria.
RESULTS: The prevalence of pathologic gastroesophageal reflux was 11.15% (89/798) (95% CI 9.10-13.48). It was higher during the first two trimesters of life, 14.62% (31/212) (95% CI 10.33-19.86) in the first trimester, and 13.76% (38/276) (95% CI 10.07-18.21) in the second trimester.
CONCLUSION: The prevalence of pathologic gastroesophageal reflux within the group of children examined concurred with previously published studies, with predominance, therefore, of regurgitant infants.

Entities:  

Mesh:

Year:  2004        PMID: 15309230

Source DB:  PubMed          Journal:  J Pediatr (Rio J)        ISSN: 0021-7557            Impact factor:   2.197


  4 in total

1.  Prevalence and management of gastroesophageal reflux disease in children and adolescents: a nationwide cross-sectional observational study.

Authors:  Léonie Martigne; Pierre-Henri Delaage; Florence Thomas-Delecourt; Geneviève Bonnelye; Philippe Barthélémy; Frédéric Gottrand
Journal:  Eur J Pediatr       Date:  2012-08-18       Impact factor: 3.183

Review 2.  Gastroesophageal reflux and congenital gastrointestinal malformations.

Authors:  Lucia Marseglia; Sara Manti; Gabriella D'Angelo; Eloisa Gitto; Carmelo Salpietro; Antonio Centorrino; Gianfranco Scalfari; Giuseppe Santoro; Pietro Impellizzeri; Carmelo Romeo
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

3.  4-aminobutyrate aminotransferase (ABAT): genetic and pharmacological evidence for an involvement in gastro esophageal reflux disease.

Authors:  Johan Jirholt; Bengt Asling; Paul Hammond; Geoffrey Davidson; Mikael Knutsson; Anna Walentinsson; Jörgen M Jensen; Anders Lehmann; Lars Agreus; Maria Lagerström-Fermer
Journal:  PLoS One       Date:  2011-04-28       Impact factor: 3.240

4.  Collagen type III alpha I is a gastro-oesophageal reflux disease susceptibility gene and a male risk factor for hiatus hernia.

Authors:  B Asling; J Jirholt; P Hammond; M Knutsson; A Walentinsson; G Davidson; L Agreus; A Lehmann; M Lagerström-Fermer
Journal:  Gut       Date:  2009-04-26       Impact factor: 23.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.